Use of Intravenous Polymyxin B During Continuous Venovenous Hemodialysis
- 1 April 2004
- journal article
- case report
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 23 (4), 340-341
- https://doi.org/10.1007/s10096-004-1106-8
Abstract
Described here is the case of a 23-year-old male with Acinetobacter baumannii sepsis and acute renal failure requiring continuous venovenous hemodialysis treated successfully with intravenous polymyxin B. The drug was administered as a loading dose of 2.5 mg/kg, followed by 2 doses of 1 mg/kg on days 4 and 8, then 0.8 mg/kg daily to complete a 24-day course. A discussion of dosing recommendations for polymyxins in dialysis is presented.Keywords
This publication has 11 references indexed in Scilit:
- Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patientsCritical Care, 2003
- Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative BacteriaAnnals of Pharmacotherapy, 1999
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- Colistin toxicity. Neuromuscular and renal manifestations. Two cases treated by hemodialysis.1973
- The polymyxins.1970
- Peritoneal dialysis in colistin intoxication: Report of a caseThe Journal of Pediatrics, 1969
- The Effects of Renal Impairment, Peritoneal Dialysis, and Hemodialysis on Serum Sodium Colistimethate LevelsAnnals of Internal Medicine, 1968
- Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis.BMJ, 1968
- Removal and Absorption of Antibiotics in Patients with Renal Failure Undergoing Peritoneal DialysisAnnals of Internal Medicine, 1967
- Serum Concentrations of Colistin in Patients with Normal and Impaired Renal FunctionNew England Journal of Medicine, 1964